等待開盤 06-05 09:30:00 美东时间
+0.745
+4.63%
Pebblebrook Hotel ( ($PEB) ) just unveiled an announcement. Pebblebrook Hotel T...
06-03 05:22
Pebblebrook forecasts FY 2026 adjusted FFO per share of $1.6-$1.7 Pebblebrook forecast same-property RevPAR growth of 2.75%-4.75% for FY 2026; total RevPAR growth seen at 3%-5%. Adjusted EBITDAre outlook set at $334.5 million-$346.5 million; adjusted FFO per diluted share projected at $1.6-$1.7. Q2
06-02 18:22
今日重点评级关注:Ascendiant Capital:维持RenovoRx"买入"评级,目标价从13.5美元升至14美元;BTIG:维持Jade Biosciences"买入"评级,目标价从39美元升至74美元
06-02 16:25
Pebblebrook Hotel (NYSE:PEB) affirms Q2 FFO guidance from $0.58-$0.62 to $0.58-$0.62 vs $0.60 analyst estimate..
05-28 22:19
今日重点评级关注:Tigress Financial:维持英伟达"强力买入"评级,目标价从360美元升至425美元;康托·菲茨杰拉德:维持DeFi Development"超配"评级,目标价从6美元升至7美元
05-28 19:00
Truist Securities analyst Gregory Miller upgrades Pebblebrook Hotel (NYSE:PEB) from Hold to Buy and raises the price target from $14 to $17.
05-28 01:44
今日重点评级关注:瑞杰金融:上调InflaRx评级至"强烈买入",目标价从7美元升至9美元;巴克莱:维持Orchestra BioMed Hldgs"超配"评级,目标价从12美元升至13美元
05-14 14:32
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
Morgan Stanley analyst Stephen Grambling maintains Pebblebrook Hotel (NYSE:PEB) with a Underweight and raises the price target from $10 to $12.
05-13 01:05
今日重点评级关注:Benchmark:维持史密斯微软件"买入"评级,目标价从2美元升至2.5美元;Citizens:维持DBV Technologies"跑赢大市"评级,目标价从47美元升至55美元
05-04 16:04